Latest Euclidean Capital LLC Stock Portfolio

$392Million– No. of Holdings #10

Euclidean Capital LLC Performance:
2026 Q1: 2.51%YTD: 2.51%2025: 13.33%

Performance for 2026 Q1 is 2.51%, and YTD is 2.51%, and 2025 is 13.33%.

About Euclidean Capital LLC and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Euclidean Capital LLC reported an equity portfolio of $392.3 Millions as of 31 Mar, 2026.

The top stock holdings of Euclidean Capital LLC are VEU, VB, AMPS. The fund has invested 62.1% of it's portfolio in VANGUARD INTL EQUITY INDEX F and 26% of portfolio in VANGUARD INDEX FDS.

The fund managers got completely rid off SPDR S&P 500 ETF TR (SPY) and RAPT THERAPEUTICS INC (RAPT) stocks. The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU).
Euclidean Capital LLC Equity Portfolio Value
Last Reported on: 15 May, 2026

Euclidean Capital LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Euclidean Capital LLC made a return of 2.51% in the last quarter. In trailing 12 months, it's portfolio return was 18.78%.
  • Performance
  • S&P 500

New Buys

No new stocks were added by Euclidean Capital LLC

Additions

Ticker% Inc.
vanguard intl equity index f8.47

Additions to existing portfolio by Euclidean Capital LLC

Reductions

None of the existing positions were reduced by Euclidean Capital LLC

Sold off

Ticker$ Sold
rapt therapeutics inc-2,785,270
spdr s&p 500 etf tr-2,798,600

Euclidean Capital LLC got rid off the above stocks

Sector Distribution

Euclidean Capital LLC has about 88.1% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Utilities
Sector%
Others88.1
Healthcare7.5
Utilities4.4

Market Cap. Distribution

Euclidean Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • MID-CAP
  • MICRO-CAP
Category%
UNALLOCATED88.1
SMALL-CAP5.1
MID-CAP4.4
MICRO-CAP2.4

Stocks belong to which Index?

About 11.3% of the stocks held by Euclidean Capital LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others88.7
RUSSELL 200011.3
Top 5 Winners (%)%
ORIC
oric pharmaceuticals inc
54.9 %
ALEC
alector inc
37.8 %
SRZN
surrozen inc
28.9 %
VB
vanguard index fds
2.7 %
VEU
vanguard intl equity index f
2.0 %
Top 5 Winners ($)$
VEU
vanguard intl equity index f
4.8 M
ORIC
oric pharmaceuticals inc
4.4 M
VB
vanguard index fds
2.7 M
ALEC
alector inc
0.8 M
SRZN
surrozen inc
0.6 M
Top 5 Losers (%)%
SRZN
surrozen inc
-20.0 %
AMPS
ishares tr
-13.3 %
FHTX
foghorn therapeutics inc
-11.5 %
TNYA
tenaya therapeutics inc
-2.7 %
PMVP
pmv pharmaceuticals inc
-0.8 %
Top 5 Losers ($)$
AMPS
ishares tr
-2.7 M
FHTX
foghorn therapeutics inc
-1.0 M
PMVP
pmv pharmaceuticals inc
0.0 M
TNYA
tenaya therapeutics inc
0.0 M
SRZN
surrozen inc
0.0 M

Euclidean Capital LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Euclidean Capital LLC

Euclidean Capital LLC has 10 stocks in it's portfolio. AMPS proved to be the most loss making stock for the portfolio. VEU was the most profitable stock for Euclidean Capital LLC last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions